Metabolic Vulnerabilities in Multiple Myeloma

SIMPLE SUMMARY: The advent of novel therapeutics has revolutionized the therapeutic scene of multiple myeloma (MM) and improved clinical outcomes significantly. Nonetheless, the disease remains incurable, especially in patients with refractory and relapsed disease. The emerging field of cancer metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Julia S. L., Chong, Phyllis S. Y., Chng, Wee-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029117/
https://www.ncbi.nlm.nih.gov/pubmed/35454812
http://dx.doi.org/10.3390/cancers14081905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029117/
https://www.ncbi.nlm.nih.gov/pubmed/35454812
http://dx.doi.org/10.3390/cancers14081905

Ejemplares similares